Literature DB >> 12873865

Cognitive decline in Down syndrome.

Maria Luisa Margallo-Lana, Clive Ballard, Chris Morris, David Kay, Stephen Tyrer, Brian Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12873865     DOI： 10.1001/archneur.60.7.1024-a

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  5 in total

1.  Alzheimer disease: Treatment of Alzheimer disease in Down syndrome.

Authors:  Alberto C Costa
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

Review 2.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

Review 3.  On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome.

Authors:  Alberto C S Costa
Journal:  Dev Neurosci       Date:  2011-09-02       Impact factor: 2.984

Review 4.  Dementia in Down syndrome: unique insights for Alzheimer disease research.

Authors:  Ira T Lott; Elizabeth Head
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

Review 5.  Pharmacological interventions for cognitive decline in people with Down syndrome.

Authors:  Nuala Livingstone; Jennifer Hanratty; Rupert McShane; Geraldine Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.